Molecular characterization and reclassification of a 1.18 Mbp DMD duplication following positive carrier screening for Duchenne/Becker muscular dystrophy

Abstract A 2‐month‐old male patient harboring a duplication of DMD exons 1–7 classified as pathogenic by an outside institution presented with mildly elevated creatine phosphokinase (CK); molecular breakpoint analysis by our laboratory reclassified the duplication as likely benign. To date, proband...

Full description

Bibliographic Details
Main Authors: Cinthya J. Zepeda‐Mendoza, Jordan E. Bontrager, Camille F. Fisher, Amber McDonald, Jaya K. George‐Abraham, Linda Hasadsri
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.6008